Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001731122-21-001934
Filing Date
2021-11-15
Accepted
2021-11-15 16:08:42
Documents
61
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 e3264_10-q.htm   iXBRL 10-Q 666187
2 e3264_ex31-1.htm EX-31.1 8569
3 e3264_ex31-2.htm EX-31.2 8516
4 e3264_ex32-1.htm EX-32.1 4624
5 e3264_ex32-2.htm EX-32.2 4727
  Complete submission text file 0001731122-21-001934.txt   4394436

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE enob-20210930.xsd EX-101.SCH 36469
7 XBRL CALCULATION FILE enob-20210930_cal.xml EX-101.CAL 48317
8 XBRL DEFINITION FILE enob-20210930_def.xml EX-101.DEF 172677
9 XBRL LABEL FILE enob-20210930_lab.xml EX-101.LAB 326179
10 XBRL PRESENTATION FILE enob-20210930_pre.xml EX-101.PRE 277738
11 EXTRACTED XBRL INSTANCE DOCUMENT e3264_10-q_htm.xml XML 616316
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
Enochian Biosciences Inc (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-38758 | Film No.: 211410536
SIC: 2834 Pharmaceutical Preparations